PL2997158T3 - Sposób wyznaczania ryzyka powstania toksyczności wywołanej promieniowaniem po ekspozycji na promieniowanie - Google Patents

Sposób wyznaczania ryzyka powstania toksyczności wywołanej promieniowaniem po ekspozycji na promieniowanie

Info

Publication number
PL2997158T3
PL2997158T3 PL14721386T PL14721386T PL2997158T3 PL 2997158 T3 PL2997158 T3 PL 2997158T3 PL 14721386 T PL14721386 T PL 14721386T PL 14721386 T PL14721386 T PL 14721386T PL 2997158 T3 PL2997158 T3 PL 2997158T3
Authority
PL
Poland
Prior art keywords
radiation
exposure
risk
determining
induced toxicity
Prior art date
Application number
PL14721386T
Other languages
English (en)
Inventor
Philippe Lambin
Georgi Ilkov Nalbantov
Hubertus Julius Maria Smeets
An Mieke Voets
Original Assignee
Univ Maastricht
Acad Ziekenhuis Maastricht
Stichting Maastricht Radiation Oncology Maastro Clinic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maastricht, Acad Ziekenhuis Maastricht, Stichting Maastricht Radiation Oncology Maastro Clinic filed Critical Univ Maastricht
Publication of PL2997158T3 publication Critical patent/PL2997158T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL14721386T 2013-05-13 2014-05-05 Sposób wyznaczania ryzyka powstania toksyczności wywołanej promieniowaniem po ekspozycji na promieniowanie PL2997158T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13167540.7A EP2803733A1 (en) 2013-05-13 2013-05-13 Method for determining the risk of developing severe dyspnea after radiation therapy
EP14721386.2A EP2997158B1 (en) 2013-05-13 2014-05-05 Method for determining the risk of developing radiation-induced toxicity after exposure to radiation
PCT/EP2014/059089 WO2014184028A1 (en) 2013-05-13 2014-05-05 Method for determining the risk of developing radiation-induced toxicity after exposure to radiation

Publications (1)

Publication Number Publication Date
PL2997158T3 true PL2997158T3 (pl) 2018-01-31

Family

ID=48325515

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14721386T PL2997158T3 (pl) 2013-05-13 2014-05-05 Sposób wyznaczania ryzyka powstania toksyczności wywołanej promieniowaniem po ekspozycji na promieniowanie

Country Status (8)

Country Link
US (1) US20160160287A1 (pl)
EP (2) EP2803733A1 (pl)
CA (1) CA2910924A1 (pl)
DK (1) DK2997158T3 (pl)
ES (1) ES2644325T3 (pl)
NO (1) NO2997158T3 (pl)
PL (1) PL2997158T3 (pl)
WO (1) WO2014184028A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220065863A1 (en) * 2017-12-11 2022-03-03 Georgetown University Predictive biomarkers for adverse effects of radiation therapy
EP3714937A1 (en) * 2019-03-28 2020-09-30 Koninklijke Philips N.V. Determining hematologic toxicity risk following radiotherapy
EP4456979A4 (en) * 2021-12-30 2025-12-31 Rhode Island Hospital GLIOBLASTOMA TREATMENT METHODS MINIMIZING RADIATION DAMAGE IN SENSITIVE PATIENTS
IL327223A (en) * 2023-09-21 2026-05-01 Univ Texas Novel mitochondria targeting signal peptides and their uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070190534A1 (en) * 2001-06-11 2007-08-16 Genesis Genomics Inc. Mitochondrial sites and genes associated with prostate cancer

Also Published As

Publication number Publication date
NO2997158T3 (pl) 2017-12-23
WO2014184028A1 (en) 2014-11-20
CA2910924A1 (en) 2014-11-20
ES2644325T3 (es) 2017-11-28
EP2997158B1 (en) 2017-07-26
US20160160287A1 (en) 2016-06-09
EP2997158A1 (en) 2016-03-23
DK2997158T3 (da) 2017-11-06
EP2803733A1 (en) 2014-11-19

Similar Documents

Publication Publication Date Title
SG10202101355PA (en) Method and system for gross settlement by use of an opaque blockchain
IL240009A0 (en) 193 nm laser and test system
IL239679A0 (en) Imaging device with scene-adapted automatic exposure compensation
HUE049191T2 (hu) Eljárás radioaktív jód ártalmatlanítására
GB2522983B (en) Method and apparatus for radiation dosimetry utilizing fluorescent imaging with precision correction
ZA202001575B (en) System for measuring components of solar radiation
HUE053751T2 (hu) Eljárás iopamidol elõállítására
GB2544118B (en) Inspection of nuclear waste
IL235115A (en) Method for Preparing Imidodisulfuryl Compounds
DK3024816T3 (da) Ppar-sparende forbindelser til behandling af metaboliske sygdomme
GB2520086B (en) Method of measuring isotope ratio
DK2997158T3 (da) Fremgangsmåde til bestemmelse af risikoen for udvikling af strålingsinduceret toksicitet efter eksponering for stråling
EP3047306A4 (en) Radiation exposure self test (rest) - optimized personal dosimetry and kiosk for reliably indicating exposure to radiation
GB201802885D0 (en) Method of neutron tomography
GB201600208D0 (en) Radiation imaging
TWI560311B (en) Method for forming film
ZA201600408B (en) Formulation of metaxalone
ZA201600480B (en) Methods for reducing the occurrence of hot flashes
ZA201600764B (en) Method for long-term storage of waste nuclear
GB201301975D0 (en) New method for the purpose of safening
EP2984504A4 (en) RADIATION DETECTOR AND METHOD
DE102014100152A8 (de) Kontrollwaagengestell
PL2950468T3 (pl) Określanie ekspozycji na promieniowanie
GB2520205B (en) Method & apparatus for fast determination of unknown radiation dose
TH1501002313B (th) วิธีการประเมินปริมาณการคืนตัว